(1-hexyl-1H-indol-3-yl)-1-naphthalenylmethanone: a synthetic cannabinoid; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 52224389 |
| SCHEMBL ID | 16201689 |
| MeSH ID | M0569799 |
| Synonym |
|---|
| AKOS015839952 |
| FT-0669204 |
| FT-0669203 |
| (1-hexyl-1h-indol-3-yl)(naphthalen-1-yl)methanone |
| A4550 |
| (1-hexyl-1h-indol-3-yl)-1-naphthalenylmethanone |
| 209414-08-4 |
| dea no. 7019 |
| 0z73828o4j , |
| unii-0z73828o4j |
| 1-hexyl-3-(1-naphthoyl)indole |
| 1-hexyl-3-(naphthalen-1-oyl)indole |
| jwh-019 |
| CCG-208723 |
| jwh 019 |
| PALJPGHWDUHUPO-UHFFFAOYSA-N |
| j2.929.918h , |
| methanone, (1-hexyl-1h-indol-3-yl)-1-naphthalenyl- |
| DTXSID70175118 |
| SCHEMBL16201689 |
| Q423592 |
| (1-hexylindol-3-yl)-naphthalen-1-ylmethanone |
| jwh-019, 1mg/ml in methanol |
| jwh-019, 0.1mg/ml in methanol |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (26.05) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (20.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||